ALPINE IMMUNE SCIENCES, INC. Accounts Receivable
ALPINE IMMUNE SCIENCES, INC. had Accounts Receivable of $42.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2024-05-09
- 2024-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $42.00K.
- 2023-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $167.00K.
- 2023-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $219.00K.
- 2023-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $284.00K.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2024-03-31 | $42.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $167.00K 10-Q · filed 2024-05-09 | |
| 2023-09-30 | $219.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $284.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $668.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $392.00K 10-K · filed 2024-03-20 | |
| 2022-09-30 | $382.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.32M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $132.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $25.00M 10-K · filed 2023-03-23 | |
| 2021-06-30 | $45.34M 10-Q · filed 2021-08-10 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-17 | $304.00K 10-Q · filed 2021-08-10 |